Services

In 2003 FOCUS has expanded its operations to Moscow, Russia and recently to Belgrade, Serbia in order to enhance patient recruitment capabilities.

FOCUS services include:

Phase I / IIa studies (SD/MD) in patient populations (incl. treatment naive patients): PoC / first into patient studies, efficacy / dose finding studies, PK/PD studies (e.g. renally/hepatically impaired patients)
Phase II and III multicenter studies with local project management and monitoring activities, including volunteer recruitment, site and investigator selection
Comprehensive full-service regulatory support (EC/MoH approval, drug import, etc.)

Services In 2003 FOCUS has expanded its operations to Moscow, Russia and recently to Belgrade, Serbia in order to enhance patient recruitment capabilities. FOCUS services include: Phase I / IIa studies (SD/MD) in patient populations (incl. treatment naive patients): PoC / first into patient studies, efficacy / dose finding studies, PK/PD studies (e.g. renally/hepatically impaired patients) Phase II and III multicenter studies with local project management and monitoring activities, including volunteer recruitment, site and investigator selection Comprehensive full-service regulatory support (EC/MoH approval, drug import, etc.)		FOCUS Moscow and Belgrade perform according to the highest quality standards - Global SOPs, global training, shared job experience and a centralized QA unit at the headquarters in Neuss - all contribute towards maintaining high quality standards.